Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from
More
Terrassa (Barcelona): Telstar will be exhibiting the latest developments in aseptic technology
SIRIO Group’s global Nutra-Innovation Team is rapidly intensifying efforts to create new formulations in different
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and
North Charleston, SC: Pharmaceutical sterilization and cleaning equipment manufacturer Belimed Life Science, North Charleston, SC, has unveiled custom wash rack
More
Maintaining optimal tablet tooling is paramount for achieving effective production outcomes. Inadequate handling and aftercare methods are responsible for 85%
More
Davis, California – Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the
MoreCopenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal vascular diseases
More
2023 will see continued packaging consolidation, increased device viscosity capabilities and a more forgiving MDR runway Paris – Ahead of next
MoreBelgium team to expand under Country Manager, Dr Pierre-Hervé Brun, providing CNS treatments to patients Brussels and Düsseldorf – Neuraxpharm
More
In-person visitor numbers rebound sharply, with record C-Suite attendance and the largest ever online presence Amsterdam – The global pharma industry
More
QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications. Botanical
More
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and
More
BRISBANE, AUS, AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and
More
